Dr. Meng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2000Fax+1 646-422-0631
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Duke University HospitalResidency, Internal Medicine, 2001 - 2004
Perelman School of Medicine at the University of PennsylvaniaClass of 2001
Certifications & Licensure
NY State Medical License 2004 - 2011
Publications & Presentations
PubMed
- 18 citationsA phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with...Geoffrey I. Shapiro, Patricia LoRusso, Daniel C. Cho, Luna Musib, Yibing Yan
Investigational New Drugs. 2021-02-01 - 122 citationsA First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors.Cristina Saura, Desamparados Roda, Susana Roselló, Mafalda Oliveira, Teresa Macarulla
Cancer Discovery. 2017-01-01 - 69 citationsA Randomized Controlled Trial of a Cardiopulmonary Resuscitation Video in Advance Care Planning for Progressive Pancreas and Hepatobiliary Cancer PatientsAndrew S. Epstein, Angelo E. Volandes, Ling Y. Chen, Kristen Gary, Yuelin Li
Journal of Palliative Medicine. 2013-05-31
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
